1. Brouqui P and Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-207.
2. Han XY, Meltzer MC, Woods JT, Fainstein V. Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov. J Clin Microbiol 2004;42:1590-5.
3. Hauser EG, Nizamuddin I, Yarusi BB, Krueger KM. An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis. Ann Clin Microbiol Antimicrob 2021;20:14.
4. Abraham R, Irwin RB, Kannappan D, Isalska B, Koroma M, Younis N. Cerebral vasculitis and Cardiobacterium valvarum endocarditis. J Med Microbiol 2012;61:1625-30.
5. Ha SM, Kim CK, Roh J, Byun JH, Yang SJ, Choi SB, et al. Application of the whole genome-based bacterial identification system, TrueBac ID, using clinical isolates that were not identified with three matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems. Ann Lab Med 2019;39:530-6.
6. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd ed. CLSI guideline M45. Wayne, PA; CLSI: 2016.
7. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128.